Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C

J Manag Care Pharm. 2009 Mar;15(2):147-50. doi: 10.18553/jmcp.2009.15.2.147.

Authors

Eduardo L Marino¹, Luis Alvarez-Rubio, Silvia Miro, Pilar Modamio, Fernando Banos, Cecilia F Lastra, Aintzane Alberdi-Leniz

Affiliation

¹ Department of Pharmacy and Pharmaceutical Technology, University of Barcelona, Faculty of Pharmacy. Av. Joan XXIII s/n, Barcelona, Spain 08028. [email protected]

No abstract available

Publication types

Clinical Trial

MeSH terms

Adult
Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Female
Genotype
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / genetics
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use
Male
Medication Adherence / statistics & numerical data
Middle Aged
Pharmacists / organization & administration*
Pharmacy Service, Hospital / organization & administration*
Polyethylene Glycols
Professional Role
Prospective Studies
Recombinant Proteins
Ribavirin / therapeutic use
Spain
Treatment Outcome

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b